Pneumococcal — Vax-Before-Travel

Fact checked by Kelley Lu, PharmD

May 8

4 min read

15-valent Pneumococcal Conjugate Vaccine Reports Very Positive Phase 2 Results

Merck V114 is a 15-valent pneumococcal conjugate vaccine candidate for the prevention of pneumococcal disease

happy healthy little girl with yellow glass frames on

Fact checked by Robert Carlson, MD

Apr 17

4 min read

UK Decreases Prevnar 13 Vaccinations From 3 to 2 Doses for Infants

CDC recommends pneumococcal conjugate vaccine (PCV) for all children younger than 2 years old

happy baby laying on a bed, only 2 shots instead of 3

Clinical Trials

Fact checked by Robert Carlson, MD

Apr 16

3 min read

20-Valent Pneumococcal Conjugate Vaccine Candidate Posts Positive Phase 2 Data

Pfizer’s PF-06482077 20vPnC vaccine candidate includes the 13 serotypes contained in Prevnar 13 vaccine

grandfather holding sleeping grand daughter

Fact checked by Robert Carlson, MD

Mar 1

4 min read

Phase 3 Study for 20-Valent Pneumococcal Vaccine Launched

Pfizer PF-06482077 is a pneumococcal disease vaccine candidate previously granted FDA Breakthrough designation

woman sitting on rock near sea

Fact checked by Kelley Lu, PharmD

Feb 15

3 min read

Pneumococcal Disease Vaccine Candidate Launches Phase 1 Study

Affinivax ASP3772 novel pneumococcal Multiple Antigen Presenting System vaccine candidate

grandparents talking and laughing